Chemoinformaics analysis of 3,7-Dimethylundecane
| Molecular Weight | 184.367 | nRot | 8 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 8 |
| Exact Molecular Weight | 184.219 | nRing | 0 |
| Solubility: LogS | -2.454 | nHRing | 0 |
| Solubility: LogP | 2.487 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 40.3802 |
| nHD | 0 | BPOL | 28.0898 |
| QED | 0.758 |
| Synth | 1.516 |
| Natural Product Likeliness | -1.588 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.019 |
| HIA | 0.004 |
| CACO-2 | -4.408 |
| MDCK | 0.0000341 |
| BBB | 0.571 |
| PPB | 0.650111 |
| VDSS | 1.186 |
| FU | 0.258477 |
| CYP1A2-inh | 0.765 |
| CYP1A2-sub | 0.756 |
| CYP2c19-inh | 0.757 |
| CYP2c19-sub | 0.834 |
| CYP2c9-inh | 0.558 |
| CYP2c9-sub | 0.678 |
| CYP2d6-inh | 0.094 |
| CYP2d6-sub | 0.251 |
| CYP3a4-inh | 0.171 |
| CYP3a4-sub | 0.524 |
| CL | 3.833 |
| T12 | 0.129 |
| hERG | 0.065 |
| Ames | 0.005 |
| ROA | 0.074 |
| SkinSen | 0.114 |
| Carcinogencity | 0.106 |
| EI | 0.964 |
| Respiratory | 0.046 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.571356 |